Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?
Ferguson
L R
LR
Cancer Research Laboratory, University of Auckland Medical School, New Zealand.
Denny
W A
WA
D000477:Alkylating Agents / Q000009:adverse effects; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D005609:Free Radicals; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D012306:Risk; D059005:Topoisomerase II Inhibitors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D005609:Free Radicals; D009153:Mutagens; D059005:Topoisomerase II Inhibitors